{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:03:09Z","timestamp":1788624189621,"version":"build-2803163510"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":587,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research at NIH","doi-asserted-by":"publisher","award":["DE019465"],"award-info":[{"award-number":["DE019465"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["DE019465"],"award-info":[{"award-number":["DE019465"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Medication-related osteonecrosis of the jaw (MRONJ) is a severe complication of antiresorptive or antiangiogenic medications, used in the treatment of bone malignancy or osteoporosis. Bone necrosis, mainly represented by osteocytic death, is always present in MRONJ sites; however, the role of osteocyte death in MRONJ pathogenesis is unknown. High mobility group box 1 (HMGB1) is a non-histone nucleoprotein that in its acetylated form accumulates in the cytoplasm, whereas non-acetylated HMGB1 localizes in the nucleus. SIRT1 deacetylase regulates cellular localization of HMGB1. Interestingly, HMGB1 is released during cell necrosis and promotes inflammation through signaling cascades, including activation of the RAGE receptor. Here, we utilized a well-established mouse MRONJ model that utilizes ligature-induced experimental periodontitis (EP) and treatment with either vehicle or zolendronic acid (ZA). Initially, we evaluated HMGB1-SIRT1 expression in osteocytes at 1, 2, and 4\u2009weeks of treatment. Significantly increased cytoplasmic and perilacunar HMGB1 expression was observed at EP sites of ZA versus vehicle (Veh) animals at all time points. SIRT1 colocalized with cytoplasmic HMGB1 and presented a statistically significant increased expression at the EP sites of ZA animals for all time points. RAGE expression was significantly higher in the submucosal tissues EP sites of ZA animals compared with those in vehicle group. To explore the significance of increased cytoplasmic and extracellular HMGB1 and increased RAGE expression in MRONJ pathogenesis, we used pharmacologic inhibitors of these molecules. Combined HMGB1\/RAGE inhibition resulted in lower MRONJ incidence with statistically significant decrease in osteonecrotic areas and bone exposure versus non-inhibitor treated ZA animals. Together, our data point to the role of HMGB1 as a central alarmin, overexpressed at early phase of MRONJ pathogenesis during osteocytic death. Moreover, HMGB1-RAGE pathway may represent a new promising therapeutic target in patients at high risk of MRONJ. \u00a9 2022 American Society for Bone and Mineral Research (ASBMR).<\/jats:p>","DOI":"10.1002\/jbmr.4637","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:39:57Z","timestamp":1655426397000},"page":"1775-1786","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Inhibition of HMGB1\/RAGE Signaling Reduces the Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Mice"],"prefix":"10.1093","volume":"37","author":[{"given":"Ioannis","family":"Gkouveris","sequence":"first","affiliation":[{"name":"Current address: private practice Athens Greece"},{"name":"Division of Diagnostic and Surgical Sciences UCLA School of Dentistry Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Hadaya","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical Sciences UCLA School of Dentistry Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseim","family":"Elzakra","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical Sciences UCLA School of Dentistry Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akrivoula","family":"Soundia","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical Sciences UCLA School of Dentistry Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Bezouglaia","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical Sciences UCLA School of Dentistry Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M","family":"Dry","sequence":"additional","affiliation":[{"name":"UCLA Department of Pathology and Laboratory Medicine David Geffen School of Medicine at UCLA Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-7345","authenticated-orcid":false,"given":"Flavia","family":"Pirih","sequence":"additional","affiliation":[{"name":"Division of Constitutive and Regenerative Sciences UCLA School of Dentistry Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2079-5870","authenticated-orcid":false,"given":"Tara","family":"Aghaloo","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical Sciences UCLA School of Dentistry Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0157-1855","authenticated-orcid":false,"given":"Sotirios","family":"Tetradis","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical Sciences UCLA School of Dentistry Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res."},{"issue":"10","key":"2024012713581169900_jbmr4637-bib-0002","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0003","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","article-title":"Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw","volume":"16","author":"Miksad","year":"2011","journal-title":"Oncologist."},{"key":"2024012713581169900_jbmr4637-bib-0004","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bone.2019.03.031","article-title":"Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ)","volume":"123","author":"Gkouveris","year":"2019","journal-title":"Bone."},{"issue":"3","key":"2024012713581169900_jbmr4637-bib-0005","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0022034517732770","article-title":"Zoledronate impairs socket healing after extraction of teeth with experimental periodontitis","volume":"97","author":"Soundia","year":"2018","journal-title":"J Dent Res."},{"issue":"4","key":"2024012713581169900_jbmr4637-bib-0006","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.joms.2013.09.008","article-title":"Stage 0 osteonecrosis of the jaw in a patient on denosumab","volume":"72","author":"Aghaloo","year":"2014","journal-title":"J Oral Maxillofac Surg."},{"issue":"11","key":"2024012713581169900_jbmr4637-bib-0007","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","article-title":"Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series","volume":"123","author":"Fedele","year":"2010","journal-title":"Am J Med."},{"issue":"6","key":"2024012713581169900_jbmr4637-bib-0008","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.oooo.2018.08.005","article-title":"Radiographic predictors of bone exposure in patients with stage 0 medication-related osteonecrosis of the jaws","volume":"126","author":"Soundia","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"issue":"4","key":"2024012713581169900_jbmr4637-bib-0009","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jbmr.2097","article-title":"RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease","volume":"29","author":"Aghaloo","year":"2014","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2353\/ajpath.2010.090592","article-title":"Bisphosphonates cause osteonecrosis of the jaw-like disease in mice","volume":"177","author":"Bi","year":"2010","journal-title":"Am J Pathol."},{"issue":"7","key":"2024012713581169900_jbmr4637-bib-0011","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jbmr.1894","article-title":"Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice","volume":"28","author":"Kang","year":"2013","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2024012713581169900_jbmr4637-bib-0012","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0013","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41418-018-0212-6","article-title":"Pyroptosis versus necroptosis: similarities, differences, and crosstalk","volume":"26","author":"Frank","year":"2019","journal-title":"Cell Death Differ."},{"issue":"2","key":"2024012713581169900_jbmr4637-bib-0014","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","article-title":"Necroptosis: the release of damage-associated molecular patterns and its physiological relevance","volume":"38","author":"Kaczmarek","year":"2013","journal-title":"Immunity."},{"issue":"2","key":"2024012713581169900_jbmr4637-bib-0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1165\/rcmb.2017-0034OC","article-title":"Involvement of alveolar epithelial cell necroptosis in idiopathic pulmonary fibrosis pathogenesis","volume":"59","author":"Lee","year":"2018","journal-title":"Am J Respir Cell Mol Biol."},{"key":"2024012713581169900_jbmr4637-bib-0016","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fimmu.2020.00484","article-title":"Targeting inflammation driven by HMGB1","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0017","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-020-00920-3","article-title":"High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies","volume":"13","author":"Yuan","year":"2020","journal-title":"J Hematol Oncol."},{"key":"2024012713581169900_jbmr4637-bib-0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","article-title":"HMGB1 in health and disease","volume":"40","author":"Kang","year":"2014","journal-title":"Mol Aspects Med."},{"issue":"7","key":"2024012713581169900_jbmr4637-bib-0019","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.4049\/jimmunol.1000803","article-title":"Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia","volume":"185","author":"Lamkanfi","year":"2010","journal-title":"J Immunol."},{"issue":"5","key":"2024012713581169900_jbmr4637-bib-0020","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.cell.2014.04.019","article-title":"RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis","volume":"157","author":"Rickard","year":"2014","journal-title":"Cell."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0021","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1038\/s41598-017-06205-z","article-title":"Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes","volume":"7","author":"Stevens","year":"2017","journal-title":"Sci Rep."},{"issue":"5425","key":"2024012713581169900_jbmr4637-bib-0022","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science."},{"issue":"11","key":"2024012713581169900_jbmr4637-bib-0023","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1681\/ASN.2009101048","article-title":"HMGB1 contributes to kidney ischemia reperfusion injury","volume":"21","author":"Wu","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"2024012713581169900_jbmr4637-bib-0024","first-page":"e1149673","article-title":"Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy","volume":"5","author":"Yang","year":"2016","journal-title":"Onco Targets Ther."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0025","doi-asserted-by":"crossref","first-page":"15971","DOI":"10.1038\/srep15971","article-title":"Deacetylation-mediated interaction of SIRT1-HMGB1 improves survival in a mouse model of endotoxemia","volume":"5","author":"Hwang","year":"2015","journal-title":"Sci Rep."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0026","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ki.2014.217","article-title":"High-mobility group box 1 is a novel deacetylation target of Sirtuin1","volume":"87","author":"Rabadi","year":"2015","journal-title":"Kidney Int."},{"key":"2024012713581169900_jbmr4637-bib-0027","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3389\/fphys.2019.00854","article-title":"Evidence for SIRT1 mediated HMGB1 release from kidney cells in the early stages of hemorrhagic shock","volume":"10","author":"Xu","year":"2019","journal-title":"Front Physiol."},{"issue":"8","key":"2024012713581169900_jbmr4637-bib-0028","first-page":"999","article-title":"Sirt1 and HMGB1 regulate the AGE-induced pro-inflammatory cytokines in human retinal cells","volume":"61","author":"Zhang","year":"2015","journal-title":"Clin Lab."},{"issue":"2","key":"2024012713581169900_jbmr4637-bib-0029","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jbmr.4185","article-title":"SIRT1 gene SNP rs932658 is associated with medication-related osteonecrosis of the jaw","volume":"36","author":"Yang","year":"2021","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jbmr.3285","article-title":"SIRT1\/HERC4 locus associated with bisphosphonate-induced osteonecrosis of the jaw: an exome-wide association analysis","volume":"33","author":"Yang","year":"2018","journal-title":"J Bone Miner Res."},{"key":"2024012713581169900_jbmr4637-bib-0031","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2009.12.046","article-title":"Tanshinone II a down-regulates HMGB1, RAGE, TLR4, NF-kappaB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia","volume":"1321","author":"Wang","year":"2010","journal-title":"Brain Res."},{"issue":"16","key":"2024012713581169900_jbmr4637-bib-0032","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1158\/1078-0432.CCR-12-0221","article-title":"S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis","volume":"18","author":"Arumugam","year":"2012","journal-title":"Clin Cancer Res."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0033","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1038\/s41598-019-45798-5","article-title":"Inhibition of the receptor for advanced glycation end-products in acute respiratory distress syndrome: a randomised laboratory trial in piglets","volume":"9","author":"Audard","year":"2019","journal-title":"Sci Rep."},{"issue":"17","key":"2024012713581169900_jbmr4637-bib-0034","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1111\/bph.13539","article-title":"The receptor for advanced glycation end products is required for \u03b2-catenin stabilization in a chemical-induced asthma model","volume":"173","author":"Yao","year":"2016","journal-title":"Br J Pharmacol."},{"issue":"8","key":"2024012713581169900_jbmr4637-bib-0035","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/jbmr.2827","article-title":"Rheumatoid arthritis exacerbates the severity of osteonecrosis of the jaws (ONJ) in mice. A randomized, prospective, controlled animal study","volume":"31","author":"de Molon","year":"2016","journal-title":"J Bone Miner Res."},{"issue":"9","key":"2024012713581169900_jbmr4637-bib-0036","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jbmr.2490","article-title":"OPG-fc but not zoledronic acid discontinuation reverses osteonecrosis of the jaws (ONJ) in mice","volume":"30","author":"de Molon","year":"2015","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0037","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.joms.2018.08.010","article-title":"Development of medication-related osteonecrosis of the jaw after extraction of teeth with experimental periapical disease","volume":"77","author":"Hadaya","year":"2019","journal-title":"J Oral Maxillofac Surg."},{"key":"2024012713581169900_jbmr4637-bib-0038","doi-asserted-by":"crossref","first-page":"108609","DOI":"10.1016\/j.biopha.2019.108609","article-title":"Tanshinone IIA attenuates sepsis-induced immunosuppression and improves survival rate in a mice peritonitis model","volume":"112","author":"Gao","year":"2019","journal-title":"Biomed Pharmacother."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0039","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jbmr.3581","article-title":"Clinically relevant doses of sclerostin antibody do not induce osteonecrosis of the jaw (ONJ) in rats with experimental periodontitis","volume":"34","author":"Hadaya","year":"2019","journal-title":"J Bone Miner Res."},{"issue":"9","key":"2024012713581169900_jbmr4637-bib-0040","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies","volume":"44","author":"Boonyapakorn","year":"2008","journal-title":"Oral Oncol."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0041","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5114\/aoms.2014.40738","article-title":"Association of dental and periodontal status with bisphosphonate-related osteonecrosis of the jaws. A retrospective case controlled study","volume":"10","author":"Kos","year":"2014","journal-title":"Archiv Med Sci."},{"issue":"5","key":"2024012713581169900_jbmr4637-bib-0042","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol."},{"issue":"9","key":"2024012713581169900_jbmr4637-bib-0043","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41584-020-0455-8","article-title":"Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease","volume":"16","author":"Anderton","year":"2020","journal-title":"Nat Rev Rheumatol."},{"issue":"11","key":"2024012713581169900_jbmr4637-bib-0044","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nri3743","article-title":"Regulated cell death and inflammation: an auto-amplification loop causes organ failure","volume":"14","author":"Linkermann","year":"2014","journal-title":"Nat Rev Immunol."},{"issue":"2","key":"2024012713581169900_jbmr4637-bib-0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: the expanding network of non-apoptotic cell death pathways","volume":"15","author":"Berghe","year":"2014","journal-title":"Nat Rev Mol Cell Biol."},{"key":"2024012713581169900_jbmr4637-bib-0046","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 is a therapeutic target for sterile inflammation and infection","volume":"29","author":"Andersson","year":"2011","journal-title":"Annu Rev Immunol."},{"key":"2024012713581169900_jbmr4637-bib-0047","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08916930701356978","article-title":"HMGB1: a signal of necrosis","volume":"40","author":"Angela","year":"2007","journal-title":"Autoimmunity."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0048","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cei.12417","article-title":"The effect of cell death in the initiation of lupus nephritis","volume":"179","author":"Fenton","year":"2015","journal-title":"Clin Exp Immunol."},{"issue":"6","key":"2024012713581169900_jbmr4637-bib-0049","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.4049\/jimmunol.178.6.3856","article-title":"A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1","volume":"178","author":"Li","year":"2007","journal-title":"J Immunol."},{"issue":"5","key":"2024012713581169900_jbmr4637-bib-0050","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00395-011-0192-x","article-title":"Necrotic cell death in atherosclerosis","volume":"106","author":"Martinet","year":"2011","journal-title":"Basic Res Cardiol."},{"issue":"3","key":"2024012713581169900_jbmr4637-bib-0051","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pharmthera.2013.11.001","article-title":"An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies","volume":"141","author":"Musumeci","year":"2014","journal-title":"Pharmacol Ther."},{"issue":"4","key":"2024012713581169900_jbmr4637-bib-0052","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10495-009-0320-3","article-title":"Cell death during sepsis: integration of disintegration in the inflammatory response to overwhelming infection","volume":"14","author":"Pinheiro da Silva","year":"2009","journal-title":"Apoptosis."},{"issue":"1\u20132","key":"2024012713581169900_jbmr4637-bib-0053","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbagrm.2009.11.014","article-title":"High-mobility group box 1 and cancer","volume":"1799","author":"Tang","year":"2010","journal-title":"Biochim Biophys Acta."},{"issue":"5","key":"2024012713581169900_jbmr4637-bib-0054","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00005-012-0183-0","article-title":"The role of glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy","volume":"60","author":"Smolarczyk","year":"2012","journal-title":"Arch Immunol Ther Exp."},{"issue":"9","key":"2024012713581169900_jbmr4637-bib-0055","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1016\/j.transproceed.2011.09.100","article-title":"High-mobility group box 1 expressions in hypoxia-induced damaged mouse islets","volume":"43","author":"Itoh","year":"2011","journal-title":"Transplant Proc."},{"issue":"16","key":"2024012713581169900_jbmr4637-bib-0056","doi-asserted-by":"crossref","first-page":"13869","DOI":"10.1074\/jbc.M110.175414","article-title":"Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner","volume":"286","author":"Chen","year":"2011","journal-title":"J Biol Chem."},{"key":"2024012713581169900_jbmr4637-bib-0057","doi-asserted-by":"crossref","first-page":"682762","DOI":"10.3389\/fonc.2021.682762","article-title":"SIRT1\/PGC-1\u03b1\/PPAR-\u03b3 correlate with hypoxia-induced chemoresistance in non-small cell lung cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol."},{"issue":"12","key":"2024012713581169900_jbmr4637-bib-0058","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41419-020-03293-0","article-title":"Sirtuin 1-dependent regulation of high mobility box 1 in hypoxia-reoxygenated brain microvascular endothelial cells: roles in neuronal amyloidogenesis","volume":"11","author":"Lee","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"2024012713581169900_jbmr4637-bib-0059","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1073\/pnas.1522288113","article-title":"Critical role of RAGE and HMGB1 in inflammatory heart disease","volume":"113","author":"Bangert","year":"2016","journal-title":"Proc Natl Acad Sci."},{"issue":"2","key":"2024012713581169900_jbmr4637-bib-0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/cells9020383","article-title":"Impact of HMGB1, RAGE, and TLR4 in Alzheimer's disease (AD): from risk factors to therapeutic targeting","volume":"9","author":"Paudel","year":"2020","journal-title":"Cell."},{"issue":"1","key":"2024012713581169900_jbmr4637-bib-0061","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40001-020-00406-5","article-title":"Mechanism of HMGB1-RAGE in Kawasaki disease with coronary artery injury","volume":"25","author":"Qian","year":"2020","journal-title":"Eur J Med Res."},{"issue":"2","key":"2024012713581169900_jbmr4637-bib-0062","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11010-020-03928-y","article-title":"AGE-RAGE synergy influences programmed cell death signaling to promote cancer","volume":"476","author":"Waghela","year":"2021","journal-title":"Mol Cell Biochem."},{"issue":"10","key":"2024012713581169900_jbmr4637-bib-0063","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.archoralbio.2012.06.007","article-title":"The relationship between receptor for advanced glycation end products expression and the severity of periodontal disease in the gingiva of diabetic and non diabetic periodontitis patients","volume":"57","author":"Abbass","year":"2012","journal-title":"Arch Oral Biol."},{"key":"2024012713581169900_jbmr4637-bib-0064","doi-asserted-by":"crossref","first-page":"816320","DOI":"10.1155\/2014\/816320","article-title":"HMGB1 localization during experimental periodontitis","volume":"2014","author":"Nogueira","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"2","key":"2024012713581169900_jbmr4637-bib-0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/life12020218","article-title":"Pathogenic molecular mechanisms in periodontitis and peri-implantitis: role of advanced glycation end products","volume":"12","author":"Plemmenos","year":"2022","journal-title":"Life."},{"key":"2024012713581169900_jbmr4637-bib-0066","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3389\/fimmu.2020.01461","article-title":"High mobility group box 1 expression in oral inflammation and regeneration","volume":"11","author":"Yamashiro","year":"2020","journal-title":"Front Immunol."},{"key":"2024012713581169900_jbmr4637-bib-0067","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3389\/fphar.2020.00568","article-title":"Tanshinone IIA suppresses proliferation and inflammatory cytokine production of synovial fibroblasts from rheumatoid arthritis patients induced by TNF-\u03b1 and attenuates the inflammatory response in AIA mice","volume":"11","author":"Du","year":"2020","journal-title":"Front Pharmacol."},{"issue":"12","key":"2024012713581169900_jbmr4637-bib-0068","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3109\/13880209.2015.1005753","article-title":"Protective effects of tanshinone IIA on myocardial ischemia reperfusion injury by reducing oxidative stress, HMGB1 expression, and inflammatory reaction","volume":"53","author":"Hu","year":"2015","journal-title":"Pharm Biol."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.4637","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.4637","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/9\/1775\/55456886\/jbmr4637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/9\/1775\/55456886\/jbmr4637.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:45:28Z","timestamp":1710326728000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/37\/9\/1775-1786\/7516628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":68,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,6,16]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4637","relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBMR.4637\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4637\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4637\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4637\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4637\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4637\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4637\/v2\/review1","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2021-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}